An <i>in vivo</i> KRAS allelic series reveals distinct phenotypes of common oncogenic variants
María Paz Zafra(Cornell University), Lukas E. Dow(Cornell University)
Cited by 3
Related Papers
Generation of precision preclinical cancer models using regulated in vivo base editing
|Nature Biotechnology|2023|30
Lineage reversion drives WNT independence in intestinal cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2020|12
Rapid generation of precision preclinical cancer models using regulatable in vivo base editing
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2
Genetic mechanisms of resistance to targeted KRAS inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1